San Diego Business Journal

SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Tease photo

Three Local Startups Recognized as Tech Innovators

Three San Diego startups were named winners of a tech innovation contest by global media company Red Herring.

By Brittany Meiling July 4, 2017 1:24 p.m. share »

Eloxx Pharmaceuticals Raises $6 Million

Eloxx Pharmaceuticals, a subsidiary of La Jolla’s Sevion Therapeutics Inc., has raised $6 million.

By Brittany Meiling July 4, 2017 1:06 p.m. share »

Sorrento Therapeutics Gets FDA OK for Human Trials of Non-Opioid Pain Treatment

Local drugmaker Sorrento Therapeutics Inc. just got the OK from regulators to start human trials for a non-opioid medicine that might treat chronic pain.

By Brittany Meiling June 30, 2017 12:10 p.m. share »

Imprimis to Focus on Ophthalmology, Sells Pennsylvania Facility and Some Assets

San Diego’s Imprimis Pharmaceuticals is selling off some assets and closing a facility in Pennsylvania as part of a move to focus its research pipeline.

By Brittany Meiling June 30, 2017 11:56 a.m. share »

Earley Departs Red Cross, Joins West Health

Bill Earley has been named chief administration officer and general counsel of West Health, a group of nonprofit organizations dedicated to helping seniors successfully age in place with affordable, high-quality health and support services.

By Sarah de Crescenzo June 29, 2017 3:58 p.m. share »

AristaMD's Founder Leaves Company

Rebecca Cofinas, founder and CEO of San Diego's AristaMD, has left the digital health company.

By Sarah de Crescenzo June 29, 2017 3:51 p.m. share »

S.D.’s Reputation Draws 2 Canadian Biotechs to Town

Two Canadian biotechnology companies — both of which are developing cancer treatments — opened offices in San Diego last week.

By Brittany Meiling June 29, 2017 2:51 p.m. share »

Former Company's Drug, CEO Back in S.D. With New Firm

A drug whose failure led local biotech Celladon Corp. to fold in 2015 is coming back to San Diego, and in the hands of a former Celladon executive.

By Brittany Meiling June 29, 2017 1:21 p.m. share »

FDA Clears Quidel Corp.'s Diagnostic Test

Quidel Corp. got the green light to sell a new diagnostic test that can detect a respiratory virus in children.

By Brittany Meiling June 29, 2017 10:51 a.m. share »

Imprimis Well-Positioned for Generic Drugs Push

Federal support for more competition among drugmakers may be a boon for San Diego-based Imprimis Pharmaceuticals Inc., a maker of generic drugs meant to compete with pricier pharmaceuticals.

By Brittany Meiling June 28, 2017 4:58 p.m. share »

Neil Reisman Joins Board at Mirati Therapeutics

San Diego-based biotechnology company Mirati Therapeutics Inc., a clinical-stage company developing targeted oncology products, has added Neil Reisman to its board of directors.

By Sarah de Crescenzo June 28, 2017 4:49 p.m. share »

Aethlon Medical Says Revenues Down, Reserves Running Low

Local device maker Aethlon Medical reported that its revenues are down for fiscal 2017, and its cash reserves are being depleted.

By Brittany Meiling June 28, 2017 4:46 p.m. share »

Clinical Trial Failure Could Be End for Neothetics

San Diego’s fat-busting biotech Neothetics Inc. has been dealt yet another (likely final) blow.

By Brittany Meiling June 27, 2017 10:03 a.m. share »

Mayor Travels to Vancouver; Canadian Co. Announces Expansion to S.D.

Mayor Kevin Faulconer joined San Diego civic and business leaders in a trip to Vancouver this week to strengthen trade ties in Canada.

By Brittany Meiling June 27, 2017 9:58 a.m. share »

Eton Pharmaceuticals Inc. Raises $20M in Private Placement

Eton Pharmaceuticals Inc., a spinout from San Diego-based Imprimis Pharmaceuticals Inc., has raised $20 million in a private placement of preferred stock.

By Brittany Meiling June 23, 2017 2:05 p.m. share »